Targeting HER2-positive breast cancer: advances and future directions

SM Swain, M Shastry, E Hamilton - Nature reviews Drug discovery, 2023 - nature.com
The long-sought discovery of HER2 as an actionable and highly sensitive therapeutic target
was a major breakthrough for the treatment of highly aggressive HER2-positive breast …

An introduction to spatial transcriptomics for biomedical research

CG Williams, HJ Lee, T Asatsuma, R Vento-Tormo… - Genome Medicine, 2022 - Springer
Single-cell transcriptomics (scRNA-seq) has become essential for biomedical research over
the past decade, particularly in developmental biology, cancer, immunology, and …

Rational combinations of targeted cancer therapies: background, advances and challenges

H Jin, L Wang, R Bernards - Nature Reviews Drug Discovery, 2023 - nature.com
Over the past two decades, elucidation of the genetic defects that underlie cancer has
resulted in a plethora of novel targeted cancer drugs. Although these agents can initially be …

Challenges and Opportunities for Immunoprofiling Using a Spatial High-Plex Technology: The NanoString GeoMx® Digital Spatial Profiler

S Hernandez, R Lazcano, A Serrano, S Powell… - Frontiers in …, 2022 - frontiersin.org
Characterization of the tumor microenvironment through immunoprofiling has become an
essential resource for the understanding of the complex immune cell interactions and the …

Spatial landscapes of cancers: insights and opportunities

J Chen, L Larsson, A Swarbrick… - Nature Reviews Clinical …, 2024 - nature.com
Solid tumours comprise many different cell types organized in spatially structured
arrangements, with substantial intratumour and intertumour heterogeneity. Advances in …

Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler

H Bergholtz, JM Carter, A Cesano, MCU Cheang… - Cancers, 2021 - mdpi.com
Simple Summary In breast cancer, there is a high degree of variability in tumors and the
surrounding tissue called the tumor microenvironment (TME). To better understand tumor …

Neoadjuvant chemotherapy is associated with altered immune cell infiltration and an anti-tumorigenic microenvironment in resected pancreatic cancer

A Dias Costa, SA Väyrynen, A Chawla, J Zhang… - Clinical Cancer …, 2022 - AACR
Purpose: Neoadjuvant chemotherapy is increasingly administered to patients with
resectable or borderline resectable pancreatic ductal adenocarcinoma (PDAC), yet its …

Multiplex protein imaging in tumour biology

N de Souza, S Zhao, B Bodenmiller - Nature Reviews Cancer, 2024 - nature.com
Tissue imaging has become much more colourful in the past decade. Advances in both
experimental and analytical methods now make it possible to image protein markers in …

[HTML][HTML] Unique macrophage phenotypes activated by BMP signaling in breast cancer bone metastases

CL Ihle, DM Straign, JA Canari, KC Torkko, KL Zolman… - JCI insight, 2024 - ncbi.nlm.nih.gov
Metastatic breast cancer (mBC) tissue in bone was systematically profiled to define the
composition of the tumor microenvironment. Gene expression identified a high myeloid …

The breast tumor microenvironment: A key player in metastatic spread

LEL Terceiro, CA Edechi, NM Ikeogu, BE Nickel… - Cancers, 2021 - mdpi.com
Simple Summary The spread of breast cancer to distant parts of the body (metastasis) is the
major cause of death in breast cancer patients. Research has shown that apart from the …